Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis

Veterinary Journal

Volumn 206, Issue 1, 2015, Pages 75-82

  Roels, Elodie ^a   Krafft, Emilie ^a   Farnir, Frederic ^a   Holopainen, Saila ^b   Laurila, Henna P ^b   Rajamäki, Minna M ^b   Day, Michael J ^c   Antoine, Nadine ^a   Pirottin, Dimitri ^a   Clercx, Cecile ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Canine idiopathic pulmonary fibrosis; CCL2; Chemokine; CXCL8

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; IMMUNOREACTIVITY; LUNG LAVAGE; MALE; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; DOG DISEASE; GENETICS; LUNG; METABOLISM; VETERINARY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; DOG DISEASES; DOGS; FEMALE; IDIOPATHIC PULMONARY FIBROSIS; INTERLEUKIN-8; LUNG; MALE;

EID: 84941942118     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2015.06.001     Document Type: Article

References (35)

1. Ahn M.H., Park B.L., Lee S.H., Park S.W., Park J.S., Kim D.J., Jang A.S., Park J.S., Shin H.K., Uh S.T., et al. A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respiratory Research 2011, 12:73.
2. Antoniou K.M., Tzouvelekis A., Alexandrakis M.G., Sfiridaki K., Tsiligianni I., Rachiotis G., Tzanakis N., Bouros D., Milic-Emili J., Siafakas N.M. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006, 130:982-988.
3. Baran C.P., Opalek J.M., McMaken S., Newland C.A., O'Brien J.M., Hunter M.G., Bringardner B.D., Monick M.M., Brigstock D.R., Stromberg P.C., et al. Important roles for macrophages colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2007, 176:78-89.
4. Bonecchi R., Galliera E., Borroni E.M., Corsi M.M., Locati M., Mantovani A. Chemokines and chemokine receptors: An overview. Frontiers in Bioscience 2009, 14:540-551.
5. Capelli A., Di Stefano A., Gnemmi I., Donner C.F. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis. The European Respiratory Journal 2005, 25:701-707.
6. Corcoran B.M., Cobb M., Martin M.W., Dukes-McEwan J., French A., Fuentes V.L., Boswood A., Rhind S. Chronic pulmonary disease in West Highland white terriers. Veterinary Record 1999, 144:611-616.
7. Covvey J.R., Mancl E.E. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis. Annals of Pharmacotherapy 2014, 48:1611-1619.
8. Cui A., Anhenn O., Theegarten D., Ohshimo S., Bonella F., Sixt S.U., Peters J., Sarria R., Guzman J., Costabel U. Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration; International Review of Thoracic Diseases 2010, 80:372-378.
9. Emad A., Emad V. Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 2007, 240:60-69.
10. Fujiwara A., Kobayashi H., Masuya M., Maruyama M., Nakamura S., Ibata H., Fujimoto H., Ohnishi M., Urawa M., Naito M., et al. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. Respirology (Carlton, Vic.) 2012, 17:693-698.
11. Gharaee-Kermani M., Denholm E.M., Phan S.H. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. The Journal of Biological Chemistry 1996, 271:17779-17784.
12. Gharaee-Kermani M., McCullumsmith R.E., Charo I.F., Kunkel S.L., Phan S.H. CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. Cytokine 2003, 24:266-276.
13. Heikkila H.P., Lappalainen A.K., Day M.J., Clercx C., Rajamaki M.M. Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland white terriers with idiopathic pulmonary fibrosis. Journal of Veterinary Internal Medicine 2011, 25:433-439.
14. Heikkila-Laurila H.P., Rajamaki M.M. Idiopathic pulmonary fibrosis in West Highland white terriers. The Veterinary Clinics of North America. Small Animal Practice 2014, 44:129-142.
15. Inomata M., Kamio K., Azuma A., Matsuda K., Kokuho N., Miura Y., Hayashi H., Nei T., Fujita K., Saito Y., et al. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respiratory Research 2014, 15:16.
16. Inoshima I., Kuwano K., Hamada N., Hagimoto N., Yoshimi M., Maeyama T., Takeshita A., Kitamoto S., Egashira K., Hara N. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. American Journal of Physiology 2004, 286:1038-1044.
17. Keane M.P., Arenberg D.A., Lynch J.P., Whyte R.I., Iannettoni M.D., Burdick M.D., Wilke C.A., Morris S.B., Glass M.C., DiGiovine B., et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. Journal of Immunology 1997, 159:1437-1443.
18. Krafft E., Heikkila H.P., Jespers P., Peeters D., Day M.J., Rajamaki M.M., McEntee K., Clercx C. Serum and bronchoalveolar lavage fluid endothelin-1 concentrations as diagnostic biomarkers of canine idiopathic pulmonary fibrosis. Journal of Veterinary Internal Medicine 2011, 25:990-996.
19. Krafft E., Laurila H.P., Peters I.R., Bureau F., Peeters D., Day M.J., Rajamaki M.M., Clercx C. Analysis of gene expression in canine idiopathic pulmonary fibrosis. The Veterinary Journal 2013, 198:479-486.
20. Lilja-Maula L.I., Laurila H.P., Syrja P., Lappalainen A.K., Krafft E., Clercx C., Rajamaki M.M. Long-term outcome and use of 6-minute walk test in West Highland white terriers with idiopathic pulmonary fibrosis. Journal of Veterinary Internal Medicine 2014, 28:379-385.
21. Lobetti R.G., Milner R., Lane E. Chronic idiopathic pulmonary fibrosis in five dogs. Journal of the American Animal Hospital Association 2001, 37:119-127.
22. Martina S., Martina V., Monika M., Jan P., Libor K., Ilja S. Angiostatic versus angiogenic chemokines in IPF and EAA. Respiratory Medicine 2009, 103:1651-1656.
23. Mercer P.F., Johns R.H., Scotton C.J., Krupiczojc M.A., Konigshoff M., Howell D.C., McAnulty R.J., Das A., Thorley A.J., Tetley T.D., et al. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2009, 179:414-425.
24. Moore B.B., Kolodsick J.E., Thannickal V.J., Cooke K., Moore T.A., Hogaboam C., Wilke C.A., Toews G.B. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. The American Journal of Pathology 2005, 166:675-684.
25. Peters I.R., Peeters D., Helps C.R., Day M.J. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. Veterinary Immunology and Immunopathology 2007, 117:55-966.
26. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., Belperio J.A., Keane M.P., Strieter R.M. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. The Journal of Clinical Investigation 2004, 114:438-446.
27. Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., Colby T.V., Cordier J.F., Flaherty K.R., Lasky J.A., et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 2011, 183:788-824.
28. Richards T.J., Kaminski N., Baribaud F., Flavin S., Brodmerkel C., Horowitz D., Li K., Choi J., Vuga L.J., Lindell K.O., et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2012, 185:67-76.
29. Shinoda H., Tasaka S., Fujishima S., Yamasawa W., Miyamoto K., Nakano Y., Kamata H., Hasegawa N., Ishizaka A. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration; International Review of Thoracic Diseases 2009, 78:285-292.
30. Suga M., Iyonaga K., Ichiyasu H., Saita N., Yamasaki H., Ando M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. The European Respiratory Journal 1999, 14:376-382.
31. Syrja P., Heikkila H.P., Lilja-Maula L., Krafft E., Clercx C., Day M.J., Ronty M., Myllarniemi M., Rajamaki M.M. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man. Journal of Comparative Pathology 2013, 149:303-313.
32. Totani Y., Saitoh Y., Sakakibara H., Miyamori I., Ishizaki T. Clinical characterization of interleukin-8 in patients with idiopathic pulmonary fibrosis. The Journal of the Japanese Respiratory Society 2002, 40:869-874.
33. Vasakova M., Sterclova M., Kolesar L., Slavcev A., Pohunek P., Sulc J., Skibova J., Striz I. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scandinavian Journal of Immunology 2009, 69:268-274.
34. Ziegenhagen M.W., Schrum S., Zissel G., Zipfel P.F., Schlaak M., Muller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. Journal of Investigative Medicine 1998, 46:223-231.
35. Ziegenhagen M.W., Zabel P., Zissel G., Schlaak M., Muller-Quernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. American Journal of Respiratory and Critical Care Medicine 1998, 157:762-768.